Loading...
XNAS
OMCL
Market cap1.32bUSD
Jul 25, Last price  
28.27USD
1D
0.50%
1Q
-8.69%
Jan 2017
-16.61%
IPO
222.72%
Name

Omnicell Inc

Chart & Performance

D1W1MN
P/E
105.68
P/S
1.19
EPS
0.27
Div Yield, %
Shrs. gr., 5y
1.50%
Rev. gr., 5y
4.39%
Revenues
1.11b
-3.04%
121,518,000154,710,000213,081,000251,865,000213,457,000222,407,000245,535,000314,027,000380,585,000440,900,000484,559,000692,623,000716,165,000787,309,000897,027,000892,208,0001,132,018,0001,295,947,0001,147,112,0001,112,238,000
Net income
13m
P
-2,074,00010,365,00043,295,00012,724,000444,0004,892,00010,389,00016,161,00023,979,00030,518,00030,760,000603,00020,605,00037,729,00061,338,00032,194,00077,849,0005,648,000-20,371,00012,531,000
CFO
188m
+3.66%
-2,258,00019,507,00037,227,00019,535,00043,130,00020,599,00031,243,00039,484,00055,263,00065,163,00033,762,00047,937,00024,834,000103,966,000145,008,000185,870,000231,809,00077,781,000181,094,000187,722,000
Earnings
Jul 30, 2025

Profile

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.
IPO date
Aug 08, 2001
Employees
3,780
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,112,238
-3.04%
1,147,112
-11.48%
1,295,947
14.48%
Cost of revenue
731,647
744,298
811,929
Unusual Expense (Income)
NOPBT
380,591
402,814
484,018
NOPBT Margin
34.22%
35.12%
37.35%
Operating Taxes
13,062
263
(8,101)
Tax Rate
3.43%
0.07%
NOPAT
367,529
402,551
492,119
Net income
12,531
-161.51%
(20,371)
-460.68%
5,648
-92.74%
Dividends
Dividend yield
Proceeds from repurchase of equity
15,850
(25,534)
BB yield
-0.93%
1.10%
Debt
Debt current
10,518
10,761
Long-term debt
402,967
637,482
645,381
Deferred revenue
58,622
37,385
Other long-term liabilities
6,318
6,719
Net debt
(31,453)
125,224
292,856
Cash flow
Cash from operating activities
187,722
181,094
77,781
CAPEX
(36,463)
(41,474)
(60,740)
Cash from investing activities
(52,793)
(55,016)
(58,669)
Cash from financing activities
(235,578)
23,420
(20,953)
FCF
467,335
403,154
394,247
Balance
Cash
381,676
467,972
330,362
Long term investments
52,744
54,804
32,924
Excess cash
378,808
465,420
298,489
Stockholders' equity
365,750
356,981
373,696
Invested Capital
1,158,424
1,511,003
1,482,847
ROIC
27.54%
26.89%
34.28%
ROCE
24.95%
21.55%
27.14%
EV
Common stock shares outstanding
46,255
45,212
45,891
Price
44.52
18.31%
37.63
-25.37%
50.42
-72.06%
Market cap
2,059,273
21.04%
1,701,328
-26.47%
2,313,824
-73.25%
EV
2,027,820
1,826,552
2,606,680
EBITDA
470,346
498,372
583,187
EV/EBITDA
4.31
3.67
4.47
Interest
130
Interest/NOPBT
0.03%